Incident Detection of High-Risk Human Papillomavirus Infections in a Cohort of High-Risk Women Aged 25-65 Years
- PMID: 27009602
- PMCID: PMC4978366
- DOI: 10.1093/infdis/jiw074
Incident Detection of High-Risk Human Papillomavirus Infections in a Cohort of High-Risk Women Aged 25-65 Years
Abstract
Background: The risk of incident high-risk human papillomavirus (HR-HPV) infection associated with recent sexual behaviors is undefined in mid-adult women (defined as women aged 25-65 years).
Methods: Triannually, 420 female online daters aged 25-65 years submitted vaginal specimens for HPV testing and completed health and sexual behavior questionnaires. The cumulative incidence of and risk factors for incident HR-HPV detection were estimated by Kaplan-Meier and Cox proportional hazards methods.
Results: The 12-month cumulative incidence of HR-HPV detection was 25.4% (95% confidence interval [CI], 21.3%-30.1%). Current hormonal contraceptive use was positively associated with incident HR-HPV detection. Lifetime number of male sex partners was also positively associated but only among women not recently sexually active with male partners. In analysis that adjusted for hormonal contraceptive use and marital status, women reporting multiple male partners or male partners who were new, casual, or had ≥1 concurrent partnership had a hazard of incident HR-HPV detection that was 2.81 times (95% CI, 1.38-5.69 times) that for women who reported no male sex partners in the past 6 months. Thus, among women with multiple male partners or male partners who were new, casual, or had ≥1 concurrent partnership, approximately 64% of incident HR-HPV infections were attributable to one of those partners.
Conclusions: Among high-risk mid-adult women with recent new male partners, multiple male partners, or male partners who were casual or had ≥1 concurrent partnership, about two thirds of incident HR-HPV detections are likely new acquisitions, whereas about one third of cases are likely redetections of prior infections.
Keywords: HPV; human papillomavirus; incidence; mid-adult; risk factors; women.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.
Figures


Comment in
-
Human Papillomavirus DNA Detection in Older Women-Implications for Cancer Screening and Prevention.J Infect Dis. 2016 Sep 1;214(5):657-8. doi: 10.1093/infdis/jiw075. Epub 2016 Mar 23. J Infect Dis. 2016. PMID: 27009603 Free PMC article. No abstract available.
References
-
- Grant LA, Dunne EF, Chesson H, Markowitz LE. Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States. Vaccine 2011; 29:2365–70. - PubMed
-
- Castle PE, Schiffman M, Herrero R et al. . A prospective study of age trends in cervical HPV acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 2005; 191:1808–16. - PubMed
-
- Munoz N, Mendez F, Posso H et al. . Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004; 190:2077–87. - PubMed
-
- Haupt RM. Gardasil update: end-of-study (16–26 year olds) adult women (24–45 year olds) In: Presentation to the Advisory Committee on Immunization Practices by R. M. Haupt of Merck Research Laboratories on February 27, 2008, 2008. http://www.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-feb08/14-3-hp.... Accessed 2 August 2012.
-
- Burchell AN, Winer RL, de Sanjose S, Franco EL. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006; 24(suppl 3):S52–61. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous